Incyte Corp (NASDAQ:INCY) - Share price - Overview

Stock Report

Incyte Corp INCY

Last Price
$69.20

Day Change
-0.91|-1.30%

As of 20/07/2018
18:34:06 EDT | USD
Minimum 15 Minutes Delay.

Last Close70.11
Day Range69.02 - 70.11
Mkt Cap14.67Bil
52-Wk Range60.23 - 140.11
Yield %-
ISINUS45337C1027
Volume1,040,679
P/E-91.05
P/S9.41
P/CF142.30

Share Price

Financials
201520162017
More ...
Income Statement
Revenue753.751,105.721,536.22
Operating Income50.65162.42-236.03
Net Income6.53104.22-313.14
Basic EPS0.040.55-1.53
Avg. Diluted Shares Outstanding187194205
Balance Sheet
Current Assets842.38994.181,504.85
Non Current Assets165.07644.42797.73
Total Assets1,007.441,638.602,302.58
Current Liabilities168.01273.50375.40
Total Liabilities---
Total Equity171.16419.471,630.63
Cash Flow
Operating Cash Flow86.54304.76-92.99
Capital Expenditure-26.00-120.28-111.02
Free Cash Flow60.53184.48-204.01

In millions, except "Basic EPS". Currency is USD.

Company Profile

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

1,208
Key Stats
More ...
Price/Earning TTM-92.25
Price/Book9.13
Price/Sales TTM9.54
Rev Growth (3 year avg)44.28
EPS Growth (3 year avg)-
Operating Margin % TTM-15.36
Net Margin % TTM-20.38
ROE TTM-30.55
Debt/Equity0.01
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.